Advanced Renal Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer (NCT04523272) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-08-25 |
Track Advanced Renal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.